THE FACT ABOUT AOD-9604 HUMAN STUDIES THAT NO ONE IS SUGGESTING

[one] The peptide does not surface to impact amounts of insulin or IGF1 in studies thus far; consequently, it doesn't seem to trigger diabetes enhancement or induce glucose intolerance in examination designs, though more studies are necessary to examine this facet.[two]The molecule was also unwieldy to be a pill – At a molecular body weight of 1,